BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 18185852)

  • 1. Cisplatin nephrotoxicity: molecular mechanisms.
    Hanigan MH; Devarajan P
    Cancer Ther; 2003; 1():47-61. PubMed ID: 18185852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide: A novel nephroprotectant against cisplatin-induced renal toxicity.
    Dugbartey GJ; Bouma HR; Lobb I; Sener A
    Nitric Oxide; 2016 Jul; 57():15-20. PubMed ID: 27095538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of gamma-glutamyl transpeptidase or cysteine S-conjugate beta-lyase activity blocks the nephrotoxicity of cisplatin in mice.
    Townsend DM; Hanigan MH
    J Pharmacol Exp Ther; 2002 Jan; 300(1):142-8. PubMed ID: 11752109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis and cell proliferation in proximal tubular cells exposed to apoptotic bodies. Novel pathophysiological implications in cisplatin-induced renal injury.
    García-Pastor C; Blázquez-Serra R; Bosch RJ; Lucio Cazaña FJ; Fernández-Martínez AB
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2504-2515. PubMed ID: 31195118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-Glutamyl transpeptidase excretion in cisplatin-induced acute renal failure.
    Gordon JA; Gattone VH; Schoolwerth AC
    Am J Kidney Dis; 1986 Jul; 8(1):18-25. PubMed ID: 2873743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Licorice and its active compound glycyrrhizic acid ameliorates cisplatin-induced nephrotoxicity through inactivation of p53 by scavenging ROS and overexpression of p21 in human renal proximal tubular epithelial cells.
    Ju SM; Kim MS; Jo YS; Jeon YM; Bae JS; Pae HO; Jeon BH
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(4):890-899. PubMed ID: 28272690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gamma-Glutamyl transpeptidase catalyses the extracellular detoxification of cisplatin in a human cell line derived from the proximal convoluted tubule of the kidney.
    Paolicchi A; Sotiropuolou M; Perego P; Daubeuf S; Visvikis A; Lorenzini E; Franzini M; Romiti N; Chieli E; Leone R; Apostoli P; Colangelo D; Zunino F; Pompella A
    Eur J Cancer; 2003 May; 39(7):996-1003. PubMed ID: 12706370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity.
    Kaushal GP; Kaushal V; Herzog C; Yang C
    Autophagy; 2008 Jul; 4(5):710-2. PubMed ID: 18497570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of gamma-glutamyl transpeptidase.
    Hausheer FH; Shanmugarajah D; Leverett BD; Chen X; Huang Q; Kochat H; Petluru PN; Parker AR
    Cancer Chemother Pharmacol; 2010 Apr; 65(5):941-51. PubMed ID: 19714332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity.
    Mishra J; Mori K; Ma Q; Kelly C; Barasch J; Devarajan P
    Am J Nephrol; 2004; 24(3):307-15. PubMed ID: 15148457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation.
    Kim D; Park W; Lee S; Kim W; Park SK; Kang KP
    Mol Med Rep; 2018 Oct; 18(4):3665-3672. PubMed ID: 30106119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α-mediated NF-κB survival signaling impairment by cisplatin enhances JNK activation allowing synergistic apoptosis of renal proximal tubular cells.
    Benedetti G; Fredriksson L; Herpers B; Meerman J; van de Water B; de Graauw M
    Biochem Pharmacol; 2013 Jan; 85(2):274-86. PubMed ID: 23103562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.
    Wang Y; Luo X; Pan H; Huang W; Wang X; Wen H; Shen K; Jin B
    Food Chem Toxicol; 2015 Sep; 83():251-60. PubMed ID: 26032634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics.
    Wilmes A; Bielow C; Ranninger C; Bellwon P; Aschauer L; Limonciel A; Chassaigne H; Kristl T; Aiche S; Huber CG; Guillou C; Hewitt P; Leonard MO; Dekant W; Bois F; Jennings P
    Toxicol In Vitro; 2015 Dec; 30(1 Pt A):117-27. PubMed ID: 25450742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Role for Tubular Necroptosis in Cisplatin-Induced AKI.
    Xu Y; Ma H; Shao J; Wu J; Zhou L; Zhang Z; Wang Y; Huang Z; Ren J; Liu S; Chen X; Han J
    J Am Soc Nephrol; 2015 Nov; 26(11):2647-58. PubMed ID: 25788533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyl transpeptidase-deficient mice are resistant to the nephrotoxic effects of cisplatin.
    Hanigan MH; Lykissa ED; Townsend DM; Ou CN; Barrios R; Lieberman MW
    Am J Pathol; 2001 Nov; 159(5):1889-94. PubMed ID: 11696449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversial role of gamma-glutamyl transferase activity in cisplatin nephrotoxicity.
    Fliedl L; Wieser M; Manhart G; Gerstl MP; Khan A; Grillari J; Grillari-Voglauer R
    ALTEX; 2014; 31(3):269-78. PubMed ID: 24664430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cilastatin attenuates cisplatin-induced proximal tubular cell damage.
    Camano S; Lazaro A; Moreno-Gordaliza E; Torres AM; de Lucas C; Humanes B; Lazaro JA; Milagros Gomez-Gomez M; Bosca L; Tejedor A
    J Pharmacol Exp Ther; 2010 Aug; 334(2):419-29. PubMed ID: 20435919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.